Stempeutics is Drug Discovery in India that focus on cosmetic applications business. Founded in 2006. They cover business area such as developer, therapeutic, stem-cell-base medicine, medicinal product, cryopreserving, adult allogeneic mesenchymal stem cell, automate isolation, stromal vascular fraction cell, cosmetic application, healthcare provider, their patient.
2006
( 18 years old in 2024 )
Cosmetic Applications
-
3rd Floor, Manipal Hospitals Whitefield Number 143
EPIP Industrial Area, ITPL Main Road, Whitefield
Bangalore, Karnataka 560048
India
Private
developertherapeuticstem-cell-base medicinemedicinal productcryopreservingadult allogeneic mesenchymal stem cellautomate isolationstromal vascular fraction cellcosmetic applicationhealthcare providertheir patient
* We use standard office opening hours in near Stempeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stempeutics is Drug Discovery business from India that founded in 2006 (18 years old in 2024), Stempeutics business is focusing on Cosmetic Applications.
Stempeutics headquarter office and corporate office address is located in 3rd Floor, Manipal Hospitals Whitefield Number 143 EPIP Industrial Area, ITPL Main Road, Whitefield Bangalore, Karnataka 560048 India.
Stempeutics was founded in India.
In 2024, Stempeutics is currently focus on cosmetic applications sector.
Above is snippet of Google Trends for "cosmetic applications" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stempeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
